Canada markets closed

KalVista Pharmaceuticals, Inc. (KALV)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.14+0.01 (+0.08%)
At close: 04:00PM EDT
12.14 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-04-30
2022-04-30
2021-04-30
Total Revenue
0
0
0
0
Operating Expenses
Research Development
84,870
80,276
70,167
41,286
Selling General and Administrative
38,848
30,595
26,446
16,637
Total Operating Expenses
123,718
110,871
96,613
57,923
Operating Income or Loss
-123,718
-110,871
-96,613
-57,923
Total Other Income/Expenses Net
12,227
15,732
13,184
10,776
Income Before Tax
-108,300
-92,907
-82,339
-46,244
Income Tax Expense
-
0
0
0
Income from Continuing Operations
-108,300
-92,907
-82,339
-46,244
Net Income
-108,300
-92,907
-82,339
-46,244
Net Income available to common shareholders
-108,300
-92,907
-82,339
-46,244
Basic EPS
-3.03
-3.33
-3.36
-2.42
Diluted EPS
-3.03
-3.33
-3.36
-2.42
Basic Average Shares
32,848
27,891
24,473
19,094
Diluted Average Shares
32,848
27,891
24,473
19,094